×
News Home

Endo International PLC (ENDP) is up 10.26% in a Week, Should You Accumulate?

Thursday, June 30, 2022 11:43 AM | InvestorsObserver Analysts
Endo International PLC (ENDP) is up 10.26% in a Week, Should You Accumulate?

The 64 rating InvestorsObserver gives to Endo International PLC (ENDP) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 92 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, ENDP’s 64 overall rating means the stock scores better than 64 percent of all stocks.

Overall Score - 64
ENDP has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on ENDP!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Endo International PLC Stock Today?

Endo International PLC (ENDP) stock is trading at $0.43 as of 11:35 AM on Thursday, Jun 30, a decline of -$0.09, or -18.04% from the previous closing price of $0.52. The stock has traded between $0.36 and $0.46 so far today. Volume today is more active than usual. So far 77,864,814 shares have traded compared to average volume of 46,823,351 shares. Click Here to get the full Stock Report for Endo International PLC stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App